Biotène Dry Mouth Oral Rinse

Biotène is a renowned oral health brand engineered specifically for individuals experiencing xerostomia, commonly known as dry mouth. Originally developed in the United States by Laclede Professional Products in the 1980s, Biotène gained widespread clinical recognition for its enzyme-based formulation designed to moisturise and protect oral mucosal tissues.

Over the years, the brand underwent strategic corporate acquisitions, notably being acquired by GlaxoSmithKline (GSK) in 2008. In July 2022, GSK completed the demerger of its consumer healthcare business into an independent, publicly listed company named Haleon plc. Consequently, Biotène became a core asset of Haleon's oral healthcare portfolio alongside global brands like Sensodyne, Aquafresh, and Corsodyl.

For products distributed across the United Kingdom and Europe, Biotène is marketed via Haleon UK Trading Limited (formerly GlaxoSmithKline Consumer Healthcare UK Trading Limited). Manufacturing takes place across specialised oral healthcare production facilities in multiple countries, predominantly in the United States and within Europe.